Active

I.L.T.-PHARMA

Switched

BE0457997178

Rechtspersoon Private limited company 1 establishment

Schoondreef 18, 2330 Merksplas Sanitaire werkzaamheden

Active for

30 year, 3 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 537,094

▲ 328% vs 2024

Profit

Growing

€ 230,631

▲ 14591% vs 2024

Debts

Normal

€ 1.8 million

▼ 35% vs 2024

I.L.T.-PHARMA from Merksplas, company number BE0457997178, closed financial year 2025 with a result of € 230,631 after tax. For that financial year I.L.T.-PHARMA recorded a gross margin of € 537,094 and equity of € 939,798. Compared with financial year 2024, the result moved from € 1,570 to € 230,631. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on December 16, 2025.

What happened at I.L.T.-PHARMA?

What happened at I.L.T.-PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 230,631 (▲ 14591% vs 2024). Source: NBB ↗
  • Kristel Dielis became a director. NBB
  • Tom Lauwerysen became a director. NBB
  • New establishment in Merksplas. KBO
  • Start of the company according to the CBE. KBO

In short

From € 41,202 loss in 2022 to € 230,631 profit in 2025.

Paid € 80,616 in corporate taxes since 2022.

Best year ever: 2025, with € 230,631 profit.

Paid out € 990,000 in dividends to the owners in total.

A new publication or filing at I.L.T.-PHARMA? We notify you, reason included.

Follow I.L.T.-PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Tom Lauwerysen
Kristel Dielis
I.L.T.-PHARMA

Behind I.L.T.-PHARMA are Tom Lauwerysen and Kristel Dielis. The same people are also behind LT Projects.

See the full network in the app

Directors

According to the 2025 annual accounts

Tom Lauwerysen

Director

Also active at: LT Projects

since 1996

Kristel Dielis

Director

Also active at: LT Projects

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Schoondreef 18

2330 Merksplas

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0457.997.178
VAT number
BE 0457.997.178
Registered office
Schoondreef 18, 2330 Merksplas
Names & denominations
I.L.T.-PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
3 June 1996
Peppol
Active · Active since 17 Feb 2025
Activities · NACE

Sanitaire werkzaamheden

Overig loodgieterswerk

Activiteiten van holdings

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Verhuur en lease van andere machines en werktuigen en andere materiële goederen

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Managementactiviteiten van holdings

Verhuur van overige machines en werktuigen, n.e.g.

+2

Frequently asked questions

What is the enterprise number of I.L.T.-PHARMA?
The enterprise number of I.L.T.-PHARMA is BE0457997178.
What is the address of I.L.T.-PHARMA?
The registered office of I.L.T.-PHARMA is located at Schoondreef 18, 2330 Merksplas.
When was I.L.T.-PHARMA founded?
I.L.T.-PHARMA was founded on 3 June 1996.
What is the main activity of I.L.T.-PHARMA?
The main activity of I.L.T.-PHARMA is "Sanitaire werkzaamheden" (NACE code 43221).
Does I.L.T.-PHARMA have a website?
No website is currently known for I.L.T.-PHARMA.
How much profit did I.L.T.-PHARMA make in 2025?
I.L.T.-PHARMA posted a profit after taxes of € 230,631 in financial year 2025.
What is the revenue of I.L.T.-PHARMA?
As a small company, I.L.T.-PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 537,094.
How many employees does I.L.T.-PHARMA have?
According to the 2025 annual accounts, I.L.T.-PHARMA has 0 full-time equivalents (FTE).
Where can I find the annual accounts of I.L.T.-PHARMA?
I.L.T.-PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of I.L.T.-PHARMA?
According to the 2025 annual accounts, the directors of I.L.T.-PHARMA are: Tom Lauwerysen, Kristel Dielis.
Who owns I.L.T.-PHARMA?
Behind I.L.T.-PHARMA are Tom Lauwerysen and Kristel Dielis. The same people are also behind LT Projects.